Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Reiser

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
Bioorganic & Medicinal Chemistry|August 21, 2012
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moietyTamar Ginsburg-Shmuel, Michael Haas, Djordje Grbic, et al.
Journal of Medicinal Chemistry|November 25, 2010
Diadenosine 5',5''-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase inhibitorsShay Eliahu, Joanna Lecka, Georg Reiser, et al.
Journal of Medicinal Chemistry|October 9, 2015
Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5'-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of ActionSagit Azran, Ortal Danino, Daniel Förster, et al.
Neurobiology of Aging|February 6, 2010
Early neuronal dysfunction by amyloid β oligomers depends on activation of NR2B-containing NMDA receptorsRaik Rönicke, Marina Mikhaylova, Sabine Rönicke, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 14, 2012
Effects of silver nanoparticles on primary mixed neural cell cultures: uptake, oxidative stress and acute calcium responsesAndrea Haase, Stephanie Rott, Alexandre Mantion, et al.
Journal of Medicinal Chemistry|May 22, 2014
Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffoldYael Nadel, Joanna Lecka, Yocheved Gilad, et al.
Restorative Neurology and Neuroscience|January 7, 2017
Recent progress in translational research on neurovascular and neurodegenerative disordersHans-Ulrich Demuth, Rick M Dijkhuizen, Tracy D Farr, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
Bioorganic & Medicinal Chemistry|August 21, 2012
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moietyTamar Ginsburg-Shmuel, Michael Haas, Djordje Grbic, et al.
Journal of Medicinal Chemistry|November 25, 2010
Diadenosine 5',5''-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase inhibitorsShay Eliahu, Joanna Lecka, Georg Reiser, et al.
Journal of Medicinal Chemistry|October 9, 2015
Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5'-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of ActionSagit Azran, Ortal Danino, Daniel Förster, et al.
Neurobiology of Aging|February 6, 2010
Early neuronal dysfunction by amyloid β oligomers depends on activation of NR2B-containing NMDA receptorsRaik Rönicke, Marina Mikhaylova, Sabine Rönicke, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 14, 2012
Effects of silver nanoparticles on primary mixed neural cell cultures: uptake, oxidative stress and acute calcium responsesAndrea Haase, Stephanie Rott, Alexandre Mantion, et al.
Journal of Medicinal Chemistry|May 22, 2014
Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffoldYael Nadel, Joanna Lecka, Yocheved Gilad, et al.
Restorative Neurology and Neuroscience|January 7, 2017
Recent progress in translational research on neurovascular and neurodegenerative disordersHans-Ulrich Demuth, Rick M Dijkhuizen, Tracy D Farr, et al.
Pageof 15